e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pulmonary circulation I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tobacco smoke: A risk factor for pulmonary arterial hypertension? A case control study
R. Schiess, O. Senn, L. C. Huber, M. Fischler, S. Vatandaslar, R. Speich, S. Ulrich (Zurich, Switzerland)
Source:
Annual Congress 2010 - Pulmonary circulation I
Session:
Pulmonary circulation I
Session type:
Thematic Poster Session
Number:
1102
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Schiess, O. Senn, L. C. Huber, M. Fischler, S. Vatandaslar, R. Speich, S. Ulrich (Zurich, Switzerland). Tobacco smoke: A risk factor for pulmonary arterial hypertension? A case control study. Eur Respir J 2010; 36: Suppl. 54, 1102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Tobacco smoke in patients with pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Tobacco smoking factor and pulmonary pathology
Source: Eur Respir J 2001; 18: Suppl. 33, 115s
Year: 2001
Wood smoke exposure as a risk factor for obstructive pulmonary disease in women: the Barcelona study
Source: Eur Respir J 2004; 24: Suppl. 48, 2s
Year: 2004
Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease?
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Waterpipe smoking and dependence are associated with chronic obstructive pulmonary disease: A case control study
Source: Annual Congress 2011 - Smoking-related disorders
Year: 2011
Cigarette smoke is a risk factor for severity destructive processes in patients with pulmonary tuberculosis.
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Smoking and pulmonary tuberculosis: a case control study
Source: Eur Respir J 2005; 26: Suppl. 49, 190s
Year: 2005
The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012
Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017
Year: 2017
Is COPD a risk factor for increased arterial stiffness?
Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD
Year: 2008
Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017
Year: 2017
An epidemiological study of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: 104-109
Year: 2007
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Biomass smoke exposure is the main risk factor for COPD in non smoking women in a developing country
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Environmental tobacco smoke exposure and the risk of obstructive lung disease exacerbation
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Age, risk and outcomes in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept